Lysophosphatidic Acid Receptor 3 (EDG-7)

Lysophosphatidic Acid Receptor 3 (EDG-7)
SKU
EXAX1220C
Packaging Unit
100 µl
Manufacturer
Exalpha Biologicals Inc

Availability: loading...
Price is loading...
Background: Endothelial Cell Differentiation Gene-7 (EDG7) belongs to a family of G-protein coupled receptors whose ligands are lysophospholipids. The ligand for EDG7 is lysophospholipid. There are 8 known members of the EDG receptor family and they are implicated in mediating growth related effects such as induction of cellular proliferation, alterations in differentiation and survival and suppression of apoptosis. They also evoke cellular effector functions that are dependent on cytoskeletal responses such as contraction, secretion, adhesion and chemotaxis. EDG receptors are developmentally regulated and differ in tissue distribution. They couple to multiple types of G proteins to signal through ras and MAP kinase, rho, phospholipase C and several protein tyrosine kinases. EDG7 is expressed in prostate as well as other tissues.

Concentration: See vial for concentration

Formulation: Provided in 10% glycerol, 0.063 M Tris-HCl (pH 6.8), 2% SDS and 0.002% bromophenol blue, 5% 2-mercaptoethanol

Caution: This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals.
More Information
SKU EXAX1220C
Manufacturer Exalpha Biologicals Inc
Manufacturer SKU X1220C
Package Unit 100 µl
Quantity Unit STK
Application Western Blotting
Product information (PDF) Download
MSDS (PDF) Download